Frontline (FRO) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX), a U.S.-based provider of mission-critical aerospace and defense electronics, today highlighted its expanding role on U.S. fighter aircraft. Mobix Labs com…

Technical indicators are flashing bullish for three Barron's stock picks.…

Frontline remains a Strong Buy, with a revised 12-month price target of $67.50, supported by historic tanker rates. My model estimates Q3 EPS at $3.12 and Q4 at $9.39, with H2 2026 EPS totaling $12.51 and a forward 12-mo…

Syndax Pharmaceuticals remains on track, with Revuforj driving robust commercial growth and Niktimvo providing a secondary revenue stream. 3Q26 revenue surged 82% YoY to $83.3M, led by Revuforj's 90% YoY growth; operatin…

Twelve-month pilot extends Everkind's daily wellness platform to Victim Services Toronto's workforce, including its Victim Crisis Response team Toronto, Ontario--(Newsfile Corp. - November 3, 2026) - Everkind Wellness In…

What you need to know: Verizon Frontline launches the second annual App Developer Challenge with a $25,000 grand prize for innovative public safety mobile apps. The contest opens on National First Responders Day (October…
Taiwan Semiconductor Manufacturing TodayTSMTaiwan Semiconductor Manufacturing$437.12 +12.75 (+3.01%) As of 10/27/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$266.8…

Connects people, student and business work with AI to help districts move from insight to action Connects people, student and business work with AI to help districts move from insight to action…

Frontline PLC (NYSE: FRO - Get Free Report) shares hit a new 52-week high on Wednesday. The company traded as high as $59.75 and last traded at $59.11, with a volume of 3,351,103 shares. The stock had previously closed a…

Frontline PLC (NYSE: FRO - Get Free Report) gapped up before the market opened on Monday. The stock had previously closed at $56.10, but opened at $58.28. Frontline shares last traded at $59.2630, with a volume of 752,26…

Partnership recognized in both Primary and Secondary education categories Partnership recognized in both Primary and Secondary education categories…

Frontline PLC (NYSE: FRO - Get Free Report) has earned an average recommendation of "Hold" from the eleven ratings firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the …

2026 R&D Day presentation highlights include: Review of final Randomized Phase 2 overall survival results Supportive Preliminary MRD Study Data and translational findings Pathway to confirmatory readout in OVATION 3 Test…

On September 21, 2026, Frontline PLC (FRO) shares fell 3.1%, bringing the current price to $49.81. This decline comes amid a 52-week trading range of $20.47 to…

Frontline Worker Research from DailyPay and Workday Reveals Closing This Gap Unlocks Key Advantages in Recruiting, Retention and Productivity NEW YORK, Sept. 17, 2026 /PRNewswire/ -- DailyPay, the leader in On-Demand Pay…

Frontline PLC (NYSE: FRO - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $50.78 and last traded at $50.5480, with a volume of 4002429 shares traded. …

Engineers Gate Manager LP lowered its position in shares of Frontline PLC (NYSE: FRO) by 45.6% in a recent quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.…

Amundi boosted its holdings in shares of Frontline PLC (NYSE: FRO) by 162.6% during a recent quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional …

Frontline plc (the “Company” or “Frontline”) (NYSE: FRO – OSE: FRO) refers to its announcement on August 4, 2026 regarding the sale of two VLCCs. Following the completion of the sale of the two VLCCs, the Board of Direct…

Remission results nearly double published ven/aza outcomes in patients with historically limited treatment success SEATTLE, WA / ACCESS Newswire / September 3, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-st…
Kept in their own lane. A press release is the company talking, not reporting.
No upcoming events in the feeds.

